Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8400
|
pubmed:dateCreated |
1984-9-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
458
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6147519-Hepatitis B Antibodies,
pubmed-meshheading:6147519-Hepatitis B Surface Antigens,
pubmed-meshheading:6147519-Hepatitis B Vaccines,
pubmed-meshheading:6147519-Humans,
pubmed-meshheading:6147519-Male,
pubmed-meshheading:6147519-Time Factors,
pubmed-meshheading:6147519-Viral Vaccines
|
pubmed:year |
1984
|
pubmed:articleTitle |
Hepatitis B vaccination: how long does protection last?
|
pubmed:publicationType |
Letter
|